IGI Therapeutics SA, which is a wholly-owned subsidiary of Ichnos Glenmark Innovation (IGI), which is an alliance between Glenmark Pharma and Ichnos Sciences Inc....
Glenmark Pharmaceuticals on Monday, March 3, announced the acquisition and launch of Acetylcysteine injection in the United States by its subsidiary.This new product will...